Notable Efficacy of Co-Treatment with FHD-286, a Dual BRG1/BRM ATP-Ase Inhibitor, and Menin or BET Inhibitor, Decitabine or Venetoclax Against AML with MLL-r or Mutant NPM1 by Fiskus, Warren C., Piel, Jessica, Hentemann, Murphy, Mill, Christopher Peter, Birdwell, Christine, Das, Kaberi, Davis, John, Hou, Hanxi, Alhamadani, Noor, Philip, Kevin, Matthews, Alicia, Kadia, Tapan M., Daver, Naval, Loghavi, Sanam, Cuglievan, Branko, DiNardo, Courtney D., Bhalla, Kapil N.

Get full text

Preclinical Studies Demonstrating Efficacy of Tasquinimod in Models of Advanced Myeloproliferative Neoplasm (MPN) in Blastic Phase by Fiskus, Warren C., Masarova, Lucia, Mill, Christopher Peter, Birdwell, Christine, Das, Kaberi, Davis, John, Hou, Hanxi, Alhamadani, Noor, Philip, Kevin, Matthews, Alicia, Manshouri, Taghi, Kadia, Tapan M., DiNardo, Courtney D., Bose, Prithviraj, Pemmaraju, Naveen, Loghavi, Sanam, Törngren, Marie, Bhalla, Kapil N.

Get full text

Pre-Clinical Efficacy of CDK7 Inhibitor-Based Combinations in Cellular Models of Advanced Myeloproliferative Neoplasms (MPN) Transformed to AML by Fiskus, Warren C., Bose, Prithviraj, Masarova, Lucia, Mill, Christopher Peter, Birdwell, Christine, Davis, John, Das, Kaberi, Hou, Hanxi, Manshouri, Taghi, Philip, Kevin, Alhamadani, Noor, Matthews, Alicia, Loghavi, Sanam, Bhalla, Kapil N.

Get full text

Pre-Clinical Efficacy of Targeting Baf Complexes through Inhibition of the Dual Atpases BRG1 and BRM By FHD-286 in Cellular Models of AML of Diverse Genetic Background by Fiskus, Warren C., Piel, Jessica, Hentemann, Murphy, Mill, Christopher Peter, Birdwell, Christine E, Das, Kaberi, Davis, John A., Alhamadani, Noor, Philip, Kevin, Kadia, Tapan M., Daver, Naval, Loghavi, Sanam, DiNardo, Courtney D., Bhalla, Kapil N.

Get full text

Bruton's Tyrosine Kinase (BTK) Degrader Nx-2127 Exhibits Lethal Activity and Synergy with Venetoclax and BET Protein Inhibitor Against MCL Cells Sensitive or Resistant to Covalent... by Fiskus, Warren C., Das, Kaberi, Mill, Christopher Peter, Birdwell, Christine E, Davis, John A., Alhamadani, Noor, Philip, Kevin, Tan, May, Brown, Robert A, Green, Michael R, Bhalla, Kapil N.

Get full text

Efficacy of Vcp/p97 Inhibitor, CB-5339, Alone and in Combinations Against High-Risk AML, Including Those with Genetic Lesion in TP53 by Fiskus, Warren C., Das, Kaberi, Mill, Christopher Peter, Birdwell, Christine E, Davis, John A., Philip, Kevin, Alhamadani, Noor, Kadia, Tapan M., Daver, Naval, Sasaki, Koji, Takahashi, Koichi, Loghavi, Sanam, DiNardo, Courtney D., Vargas, Jesse, Bhalla, Kapil N.

Get full text

Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML by Fiskus, Warren, Mill, Christopher P, Bose, Prithviraj, Masarova, Lucia, Pemmaraju, Naveen, Dunbar, Andrew, Birdwell, Christine, Davis, John A, Das, Kaberi, Hou, Hanxi, Manshouri, Taghi, Jain, Antrix, Malovannaya, Anna, Philip, Kevin, Alhamadani, Noor, Matthews, Alicia, Lin, Katie, Flores, Lauren, Loghavi, Sanam, DiNardo, Courtney D, Su, Xiaoping, Rampal, Raajit K, Bhalla, Kapil N

Get full text

Establishment of EWARN system for the Syrian crisis: Experiences and challenges by Mala, P, Ghada, M, Wasan, A, Noor, A.A, Alhamadani, A.S, Gmach, S, Muntasir, E, Mansour, Z, Rady, A, Iliana, M, Elganainy, A, Musani, A, Malik, M.R

Get full text